AstraZeneca-MedImmune Venture Fund Overview
AstraZeneca-MedImmune Venture Fund General Information
Description
AstraZeneca-MedImmune Venture Fund was a venture capital fund managed by MedImmune Ventures. The fund was located in Gaithersburg, Maryland.
Contact Information
Fund Manager's Location
- One MedImmune Way
- Gaithersburg, MD 20878
- United States
AstraZeneca-MedImmune Venture Fund Investments (21)
AstraZeneca-MedImmune Venture Fund has made a total of 21 investments. Its most recent deal was a with G1 Therapeutics for . The deal was made on 01-Jul-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| G1 Therapeutics | 01-Jul-2016 | Drug Discovery | Clinical Trials - Phase 2 | |||
| G1 Therapeutics | 05-Feb-2015 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Astria Therapeutics | 15-Nov-2013 | Drug Discovery | Generating Revenue | |||
| G1 Therapeutics | 16-Oct-2013 | Drug Discovery | Startup | |||
| Inotek Pharmaceuticals | 27-Sep-2013 | Drug Discovery | Clinical Trials - General | |||
| Astria Therapeutics | 27-Jun-2013 | Drug Discovery | Generating Revenue | |||
| Cerapedics | 12-Dec-2012 | Surgical Devices | Generating Revenue | |||
| Astria Therapeutics | 10-Jul-2012 | Drug Discovery | Generating Revenue | |||
| Armaron Bio | 05-Dec-2011 | Early Stage VC | Biotechnology | Clinical Trials - Phase 1 | ||
| Inotek Pharmaceuticals | 11-Jun-2010 | Later Stage VC (Series D) | Drug Discovery | Clinical Trials - General |
AstraZeneca-MedImmune Venture Fund Investment Strategy
AstraZeneca-MedImmune Venture Fund Limited Partners (1)
AstraZeneca Defined Benefit Pension Plan is the sole limited partner of AstraZeneca-MedImmune Venture Fund.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| AstraZeneca Defined Benefit Pension Plan | Current | Original |
AstraZeneca-MedImmune Venture Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
AstraZeneca-MedImmune Venture Fund FAQs
-
What is AstraZeneca-MedImmune Venture Fund?
AstraZeneca-MedImmune Venture Fund was a venture capital fund managed by MedImmune Ventures.
-
Who manages AstraZeneca-MedImmune Venture Fund?
AstraZeneca-MedImmune Venture Fund is managed by MedImmune Ventures.
-
Where is AstraZeneca-MedImmune Venture Fund domiciled?
AstraZeneca-MedImmune Venture Fund is domiciled in United States.
-
What is AstraZeneca-MedImmune Venture Fund's size?
AstraZeneca-MedImmune Venture Fund has a size of $400M.
-
What type of fund is AstraZeneca-MedImmune Venture Fund?
The fund type of AstraZeneca-MedImmune Venture Fund is Venture.
-
What is the status of AstraZeneca-MedImmune Venture Fund?
AstraZeneca-MedImmune Venture Fund is liquidated.
-
What has AstraZeneca-MedImmune Venture Fund invested in?
AstraZeneca-MedImmune Venture Fund has made numerous investments in companies like G1 Therapeutics, Astria Therapeutics, and Inotek Pharmaceuticals within the Drug Discovery industry.
-
What has AstraZeneca-MedImmune Venture Fund invested in recently?
AstraZeneca-MedImmune Venture Fund's latest investment was on 01-Jul-2016 in G1 Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process